Improved Self-management for Patients on Ventricular Assist Device (VAD)

NCT04234230 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 393

Last updated 2020-11-06

No results posted yet for this study

Summary

The number of patients with end-stage heart disease requiring the implantation of ventricular assist devices (VAD) is steadily increasing. Living with a VAD exposes the patients to multiple challenges and the need to learn complex self-management skills. Inadequate self-management can lead to serious complications (e.g. bleeding or wound infections) and impair the psychosocial outcome. This study aims to provide multi-centered actual analysis of self-management capabilities as well as analyzing moderating predictors in VAD patients through standardized prevalence assessment. Using a cross-sectional design, this prevalence study will be conducted at four established German heartcenters (Freiburg, Berlin, Bad Oeynhausen, Leipzig). VAD-patients are questioned about their self-management skills using standardized Patient-reported outcome (PRO) measures. Secondary PRO measures include health-related quality of life, symptoms of anxiety and depression, post-traumatic stress symptoms, social support, and changed body-image. Relevant complications (bleeding, wound infections, thromboembolic neurological events) are taken from the patient records. Based on a conservative sample size estimation inclusion of 450 patients is envisioned. The expected results may contribute to an improved assessment of the current situation in terms of self-management skills and needs for curricular training concepts and psychosocial concomitant therapy. Long-term, the study results contribute to improve the health care for long-term VAD patients.

Conditions

  • Ventricular Assist Device
  • Self-management
  • Psychological Factors

Interventions

OTHER

Prevalence Survey

Questionnaire survey on self-management

Sponsors & Collaborators

  • University Heart Center Freiburg - Bad Krozingen

    collaborator OTHER
  • Heart and Diabetes Center North-Rhine Westfalia

    collaborator OTHER
  • German Heart Center

    collaborator OTHER
  • Heart Center Leipzig - University Hospital

    collaborator OTHER
  • University of Freiburg

    lead OTHER

Principal Investigators

  • Christiane Kugler, Prof. Dr. · University of Freiburg

  • Christiane Kugler, Prof. Dr. · University of Freiburg

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-01
Primary Completion
2020-08-31
Completion
2020-09-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04234230 on ClinicalTrials.gov